60 Degrees Pharmaceuticals, Inc.
SXTP
$2.96
$0.103.50%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -10.25M | -7.95M | -7.91M | -1.57M | -735.20K |
Total Depreciation and Amortization | 58.40K | 63.70K | 71.20K | 81.90K | 95.90K |
Total Amortization of Deferred Charges | -- | -- | 0.00 | 27.30K | 361.60K |
Total Other Non-Cash Items | 3.83M | 2.04M | 2.49M | -3.70M | -4.68M |
Change in Net Operating Assets | 257.60K | 192.60K | 1.28M | -984.00K | -317.70K |
Cash from Operations | -6.11M | -5.65M | -4.07M | -6.15M | -5.27M |
Capital Expenditure | -106.50K | -103.80K | -159.60K | -147.60K | -57.60K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -70.40K | -1.79M | -1.79M | -87.30K | -64.80K |
Cash from Investing | -176.80K | -1.89M | -1.95M | -234.90K | -122.40K |
Total Debt Issued | -- | -- | 0.00 | 0.00 | 700.00K |
Total Debt Repaid | -- | -- | 0.00 | -1.61M | -1.86M |
Issuance of Common Stock | 6.95M | 7.14M | 7.14M | 9.49M | 9.49M |
Repurchase of Common Stock | -119.10K | -101.10K | -150.40K | -150.40K | -150.40K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 16.20K | 16.20K | 64.50K | 140.60K | 17.60K |
Cash from Financing | 6.85M | 7.05M | 7.05M | 7.87M | 8.20M |
Foreign Exchange rate Adjustments | -8.60K | 500.00 | 56.70K | 64.20K | 62.30K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 556.80K | -483.10K | 1.08M | 1.56M | 2.86M |